Jingfeng Pharmaceutical(SZ:000908) Xin Lang Cai Jing·2025-10-21 13:21Core Viewpoint - Company ST Jingfeng has received a court ruling accepting a restructuring application from creditors, indicating potential financial distress and the initiation of a formal restructuring process [1] Group 1: Legal Proceedings - The Changde Intermediate People's Court in Hunan Province has accepted the restructuring application for the company [1] - Beijing Zhonglun Law Firm has been appointed as the administrator for the company's restructuring [1] Group 2: Stock Market Impact - According to the Shenzhen Stock Exchange listing rules, the company's stock will be subject to delisting risk warning starting from October 23, 2025, with the stock name changing to "*ST Jingfeng" [1] - The stock code will remain "000908," and the daily price fluctuation limit will continue to be 5% [1] - The company's stock will be suspended for trading on October 22, 2025, and will resume trading on October 23, 2025 [1]